drugset / Trial / NCT01475318
Study on Combined Use of Letrozole, Mifepristone and Misoprostol in Termination of Pregnancy
NaSingle-groupOpen-labelTreatment
Summary
By using the combination of mifepristone (anti-progestin), misoprostol (progstanglandin which stimulates uterine contraction), and letrozole (aromatise inhibitor which reduces estrogen production), the abortion process will be more effective.
Timeline
- Start
- 2011-10
- Primary completion
- 2012-06
- Completion
- 2012-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Letrozole | Other / unclassified | 10 mg | Oral |
| Subject | Mifepristone | Small molecule | 200 mg | — |
| Subject | Misoprostol | Other / unclassified | 800 ug | Other |
Indications
No indication recorded.